Therapeutic Inhibition of Sphingosine Kinase SphK2 lowers Blood Pressure Levels in an Experimental Model of Hypertension by Reducing CD4+ T‐cell Responses

Nicholas Don-doncow; Lotte Vanherle; Frank Matthes; Henning Petzka; Anja Meissner

doi:10.1096/fasebj.2020.34.s1.04663

Therapeutic Inhibition of Sphingosine Kinase SphK2 lowers Blood Pressure Levels in an Experimental Model of Hypertension by Reducing CD4+ T‐cell Responses

Nicholas Don-doncow, Lotte Vanherle, Frank Matthes, Henning Petzka, Anja Meissner

Research output: Contribution to journal › Published meeting abstract

Original language	English
Pages (from-to)	1-1
Journal	FASEB Journal
Volume	34
Issue number	S1
DOIs	https://doi.org/10.1096/fasebj.2020.34.s1.04663
Publication status	Published - 2020 Apr 1

Bibliographical note

Experimental Biology 2020 Meeting Abstracts

Subject classification (UKÄ)

Physiology

Access to Document

10.1096/fasebj.2020.34.s1.04663Licence: Other

Cite this

@article{8d31215c4efb4aef9916e316d3a9b0be,

title = "Therapeutic Inhibition of Sphingosine Kinase SphK2 lowers Blood Pressure Levels in an Experimental Model of Hypertension by Reducing CD4+ T‐cell Responses",

author = "Nicholas Don-doncow and Lotte Vanherle and Frank Matthes and Henning Petzka and Anja Meissner",

note = "Experimental Biology 2020 Meeting Abstracts",

year = "2020",

month = apr,

day = "1",

doi = "10.1096/fasebj.2020.34.s1.04663",

language = "English",

volume = "34",

pages = "1--1",

journal = "FASEB Journal",

issn = "0892-6638",

publisher = "Wiley",

number = "S1",

}

TY - JOUR

T1 - Therapeutic Inhibition of Sphingosine Kinase SphK2 lowers Blood Pressure Levels in an Experimental Model of Hypertension by Reducing CD4+ T‐cell Responses

AU - Don-doncow, Nicholas

AU - Vanherle, Lotte

AU - Matthes, Frank

AU - Petzka, Henning

AU - Meissner, Anja

N1 - Experimental Biology 2020 Meeting Abstracts

PY - 2020/4/1

Y1 - 2020/4/1

UR - https://faseb.onlinelibrary.wiley.com/toc/15306860/34/S1

U2 - 10.1096/fasebj.2020.34.s1.04663

DO - 10.1096/fasebj.2020.34.s1.04663

M3 - Published meeting abstract

SN - 0892-6638

VL - 34

SP - 1

EP - 1

JO - FASEB Journal

JF - FASEB Journal

IS - S1

ER -

Therapeutic Inhibition of Sphingosine Kinase SphK2 lowers Blood Pressure Levels in an Experimental Model of Hypertension by Reducing CD4+ T‐cell Responses

Bibliographical note

Subject classification (UKÄ)

Access to Document

Other files and links

Cite this